Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peptides”

1,723 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,723 results

Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Not applicableStudy completedNCT01637662
What this trial is testing

Natriuretic Peptide's Headache Inducing Characteristics and Effects on the Cerebral Blood Flow

Who this might be right for
HeadacheMigraine
Danish Headache Center 6
Early research (Phase 1)Looking for participantsNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Early research (Phase 1)UnknownNCT01266720
What this trial is testing

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 6
Early research (Phase 1)Ended earlyNCT01403285
What this trial is testing

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Who this might be right for
Glioblastoma
Immatics Biotechnologies GmbH 6
Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Not applicableStudy completedNCT07613879
What this trial is testing

Mulligan Mobilization and Stabilization Exercises for Sensorimotor Function in Women With Text Neck Syndrome

Who this might be right for
Neck PainText Neck SyndromeCumulative Trauma Disorders+1 more
Pamukkale University 38
Large-scale testing (Phase 3)WithdrawnNCT01860742
What this trial is testing

Randomized Phase III of PRRT Versus Interferon

Who this might be right for
Gastro-intestinal Neuroendocrine Tumors
Jules Bordet Institute
Early research (Phase 1)Looking for participantsNCT04216342
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers

Who this might be right for
Cardiovascular Disease
National Heart, Lung, and Blood Institute (NHLBI) 64
Not applicableNot Yet RecruitingNCT07538791
What this trial is testing

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

Who this might be right for
PheochromocytomasParagangliomas
Azienda USL Reggio Emilia - IRCCS 210
Early research (Phase 1)Looking for participantsNCT05870423
What this trial is testing

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors

Who this might be right for
Neuroendocrine TumorsPeptide Receptor Radionuclide Therapy
Erasmus Medical Center 24
Early research (Phase 1)Study completedNCT02673554
What this trial is testing

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 30
Not applicableLooking for participantsNCT07402356
What this trial is testing

VR Pupillometry in Cognitive Impairment

Who this might be right for
Alzheimer s DiseaseMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry 140
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Not applicableStudy completedNCT05782101
What this trial is testing

Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study

Who this might be right for
Bronchopulmonary Dysplasia; Retinopathy of Prematurity
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02754297
What this trial is testing

Personalized PRRT of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorCarcinoma, Neuroendocrine
CHU de Quebec-Universite Laval 275
Testing effectiveness (Phase 2)Study completedNCT00456027
What this trial is testing

Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)

Who this might be right for
Latent Autoimmune Diabetes in Adult (LADA)
Diamyd Therapeutics AB 160
Testing effectiveness (Phase 2)Study completedNCT01974570
What this trial is testing

Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects

Who this might be right for
Prehypertension
KGK Science Inc. 144
Not applicableLooking for participantsNCT04628429
What this trial is testing

CGRP Inhibition, Autonomic Function, and Migraine

Who this might be right for
Episodic MigraineChronic Migraine
Medical University of Vienna 120
Load More Results